HRGN (Harvard Apparatus Regenerative Technology) Dividend Yield %: 0.00% (As of Jun. 26, 2026)


HRGN Harvard Apparatus Regenerative Technology Inc HRGN
34 GF Score
Price $1.39
GF Value $5.34
Valuation Possible Value Trap
! 2 Warning Signs
View Full Analysis

What is Harvard Apparatus Regenerative Technology Dividend Yield %?

Harvard Apparatus Regenerative Technology HRGN 34 Dividend Yield % is 0.00% as of Jun. 26, 2026. GuruFocus rates HRGN with a GF Score™ of 34/100 and a GF Value™ of $5.34 (Possible Value Trap). The stock has 2 warning signs investors should review. Among 1,174 Consumer Packaged Goods companies, Harvard Apparatus Regenerative Technology ranks worse than 85178.79% on this metric.

As of today (2026-06-26), the Trailing Annual Dividend Yield of Harvard Apparatus Regenerative Technology is 0.00%.

The historical rank and industry rank for Harvard Apparatus Regenerative Technology's Dividend Yield % or its related term are showing as below:

HRGN's Dividend Yield % is not ranked *
in the Consumer Packaged Goods industry.
Industry Median: 2.855
* Ranked among companies with meaningful Dividend Yield % only.

Harvard Apparatus Regenerative Technology's Dividend Payout Ratio for the three months ended in Mar. 2026 was 0.00.

As of today (2026-06-26), the Forward Dividend Yield % of Harvard Apparatus Regenerative Technology is 0.00%.

Harvard Apparatus Regenerative Technology's Dividends per Share for the three months ended in Mar. 2026 was $0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.


Harvard Apparatus Regenerative Technology  (OTCPK:HRGN) Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


Harvard Apparatus Regenerative Technology Dividend Yield % Related Terms


Harvard Apparatus Regenerative Technology Dividend Yield % Historical Data

* Premium members only.

The historical data trend for Harvard Apparatus Regenerative Technology's Dividend Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Harvard Apparatus Regenerative Technology Dividend Yield % Chart

Harvard Apparatus Regenerative Technology Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Dividend Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Harvard Apparatus Regenerative Technology Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Dividend Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

HRGN vs DTEAF, WYGC, BFNH: Dividend Yield % Comparison

For the Packaged Foods subindustry, Harvard Apparatus Regenerative Technology's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Harvard Apparatus Regenerative Technology Dividend Yield % vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Harvard Apparatus Regenerative Technology's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Harvard Apparatus Regenerative Technology's Dividend Yield % falls into.


HRGN
34GF Score
Harvard Apparatus Regenerative Technology Inc HRGN
Dividend Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Harvard Apparatus Regenerative Technology Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

Frequently Asked Questions Learn more about Dividend Yield % →
What does a Dividend Yield % of 0.00% mean?
Harvard Apparatus Regenerative Technology (HRGN) has a Dividend Yield % of 0.00% as of Jun. 26, 2026. Dividend yield is the ratio of company dividends to the share price. View historical data on Harvard Apparatus Regenerative Technology and its competitors. According to the industry distribution chart, Harvard Apparatus Regenerative Technology ranks #999999 out of 1174 companies in the Consumer Packaged Goods industry.
Is Harvard Apparatus Regenerative Technology's Dividend Yield % too high?
Harvard Apparatus Regenerative Technology's current Dividend Yield % is 0.00%. Based on the distribution chart, Harvard Apparatus Regenerative Technology ranks #999999 out of 1174 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers. Overall, Harvard Apparatus Regenerative Technology has a GF Score™ of 34/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Harvard Apparatus Regenerative Technology's Dividend Yield % compare to DTEAF and WYGC?
According to the Consumer Packaged Goods industry distribution chart, Harvard Apparatus Regenerative Technology ranks #999999 out of 1174 companies for Dividend Yield %. This places Harvard Apparatus Regenerative Technology in the lower half of its industry. The industry median Dividend Yield % is 2.86. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Yield % for a Consumer Packaged Goods company?
The median Dividend Yield % among Consumer Packaged Goods companies is 2.86, based on 1,174 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Yield % mean?
A high Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Dividend yield is the ratio of company dividends to the share price. View historical data on Harvard Apparatus Regenerative Technology and its competitors. For the Consumer Packaged Goods industry, the median Dividend Yield % is 2.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Harvard Apparatus Regenerative Technology's current Dividend Yield % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Harvard Apparatus Regenerative Technology stock overvalued right now?
Based on GuruFocus' analysis, Harvard Apparatus Regenerative Technology (HRGN) is currently considered Possible Value Trap. The stock's GF Value™ is $5.34, compared to a current price of $1.39 — trading 74% below its estimated fair value. The current Dividend Yield % is 0.00%. Harvard Apparatus Regenerative Technology's overall GF Score™ is 34/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Yield % calculated?
Dividend Yield % is calculated from a company's financial statements. For Harvard Apparatus Regenerative Technology (HRGN), the current Dividend Yield % is 0.00% as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Harvard Apparatus Regenerative Technology (HRGN) Overvalued in 2026?

Based on GuruFocus' analysis, Harvard Apparatus Regenerative Technology stock appears to be undervalued. The current stock price of $1.39 is trading 74% below its estimated GF Value™ of $5.34. GuruFocus considers Harvard Apparatus Regenerative Technology to be Possible Value Trap.

Key valuation signals for HRGN:

  • Dividend Yield %: 0.00%
  • GF Value™: $5.34 vs. price of $1.39 (74% below fair value)
  • GF Score™: 34/100 with 2 warning signs

No single metric tells the full story. See the HRGN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Harvard Apparatus Regenerative Technology Business Description

Address 84 October Hill Road, Suite 11, Holliston, MA, USA, 01746
Harvard Apparatus Regenerative Technology is a clinical-stage biotechnology company focused on the development of regenerative medicine treatments for disorders of the gastrointestinal system and other organs that result from cancer, trauma, or birth defects. Its technology is based on a proprietary cell-therapy platform that uses a patient's own stem cells to regenerate and restore function to damaged organs. The Company has two operating and reportable segments: Regenerative Biotech, focused on the development of regenerative medicine treatments with operations currently in the United States, and Consumer Health Products relating to consumer health products with operations currently in Asia.
34GF Score

Get the complete analysis for HRGN

Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.39
Price
$5.34
GF Value